Physician profile
Peter Augustinos
NPI 1518936327
$3,156.16
in general payments reported to CMS, 2019-2025
21 companies · $1,413 in 2025
The $1,413 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.03 · 2021: $208 · 2022: $77.11 · 2023: $282 · 2024: $1,139 · 2025: $1,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,819 · Travel and Lodging: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,819.19 |
| Travel and Lodging | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,623.79 | 2022-2025 | Grafix Pl, Oasis, Stravix |
| Urgo Medical North America, LLC | $673.25 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Silk Road Medical, INC. | $170.78 | 2021 | |
| Sanara Medtech INC. | $103.63 | 2024 | Celleraterx |
| Advanced Oxygen Therapy INC. | $88.76 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Tactile Systems Technology INC | $67.68 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bsn Medical INC | $64.73 | 2023 | |
| Janssen Pharmaceuticals, INC | $55.82 | 2021-2022 | |
| Medline Industries Lp | $45.41 | 2025 | |
| Integra Lifesciences Corporation | $44.86 | 2024 | Tcc-Ez |
| Getinge USA Sales, LLC | $37.03 | 2020 | |
| Solventum Corporation | $35.28 | 2024-2025 | V.A.C.Ulta, Activ.A.C. |
| Mimedx Group, INC. | $21.00 | 2025 | |
| Angiodynamics, INC. | $18.45 | 2021 | |
| Aroa Biosurgery Incorporated | $18.27 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.47 | 2024 | Verquvo |
| Organogenesis INC. | $16.49 | 2024 | Apligraf |
| Cook Medical LLC | $15.92 | 2024 | Zilver Ptx |
| Polynovo North America LLC | $14.47 | 2025 | Novosorb Btm |
| Reprise Biomedical, INC. | $12.17 | 2025 | Miro3d |
| Kerecis Limited | $10.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Augustinos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.